Seong Soo Jeon Selected Research

Drug Therapy (Chemotherapy)

1/2023	A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy.
1/2022	A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.
2/2020	The Use of Gonadotropin-Releasing Hormone Agonist Does Not Affect the Development of Cardiovascular Disease in Prostate Cancer Patients: a Nationwide Population-Based Cohort Study.
1/2020	Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting.
10/2019	Atezolizumab in Patients with Pretreated Urothelial Cancer: a Korean Single-Center, Retrospective Study.
5/2019	A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer.
1/2019	Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.
8/2017	A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer.
5/2012	ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seong Soo Jeon Research Topics

Disease

64	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 04/2006
55	Neoplasms (Cancer) 12/2024 - 04/2006
35	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 01/2007
15	Carcinoma (Carcinomatosis) 12/2024 - 01/2014
10	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 05/2012
8	Neoplasm Metastasis (Metastasis) 04/2020 - 01/2007
7	Chronic Renal Insufficiency 09/2022 - 04/2013
7	Margins of Excision 01/2021 - 12/2014
4	Disease Progression 12/2024 - 09/2012
3	Pain (Aches) 09/2022 - 09/2011
3	Hypertrophy 01/2021 - 10/2015
3	Hypertension (High Blood Pressure) 01/2019 - 04/2013
2	Ureteral Obstruction 01/2023 - 10/2005
2	Intraoperative Complications 12/2014 - 04/2013
2	Wounds and Injuries (Trauma) 09/2012 - 06/2010
2	Pneumoperitoneum 03/2012 - 12/2010
1	Erectile Dysfunction 07/2023
1	Endometriosis 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Chromosomal Instability (Chromosome Stability) 01/2023
1	Inflammation (Inflammations) 09/2022
1	Fibrosis (Cirrhosis) 09/2022
1	Lymphatic Metastasis 03/2022
1	Extranodal Extension 03/2022
1	Sarcopenia 12/2021
1	Genomic Instability 12/2021
1	Proteinuria 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2020
1	Dementia (Dementias) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Pruritus (Itching) 10/2019
1	Fatigue 10/2019
1	Constipation 05/2019
1	Alopecia (Baldness) 05/2019
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

26	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 01/2010
11	AndrogensIBA 03/2024 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2010
6	Hormones (Hormone)IBA 01/2024 - 10/2011
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2017
6	Docetaxel (Taxotere)FDA Link 12/2021 - 12/2016
5	enzalutamideIBA 12/2023 - 01/2019
3	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2022
3	Circulating Tumor DNAIBA 10/2021 - 01/2019
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2020 - 01/2017
3	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2017
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 06/2019 - 05/2012
2	Indicators and Reagents (Reagents)IBA 01/2024 - 04/2016
2	abirateroneIBA 01/2024 - 01/2023
2	Abiraterone AcetateIBA 01/2023 - 12/2021
2	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 10/2011
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 04/2013
2	CurcuminIBA 01/2019 - 09/2016
2	Uric Acid (Urate)IBA 05/2013 - 04/2013
1	Epirubicin (Ellence)FDA LinkGeneric 01/2024
1	Prednisone (Sone)FDA LinkGeneric 01/2024
1	udenafilIBA 07/2023
1	6-bromo-2-naphthyl sulfate (BNS)IBA 07/2023
1	antiarrhythmic peptide (AAP)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	thiamine triphosphorate (TTP)IBA 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	glycine amidinotransferase (arginine-glycine amidinotransferase)IBA 05/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Poly Adenosine Diphosphate RiboseIBA 12/2021
1	Carrier Proteins (Binding Protein)IBA 11/2021
1	Insulin (Novolin)FDA Link 11/2021
1	Testosterone (Sustanon)FDA Link 03/2021
1	Alanine (L-Alanine)FDA Link 01/2020
1	LigandsIBA 01/2020
1	Aspartic Acid (Aspartate)FDA Link 01/2020
1	Serum AlbuminIBA 12/2019
1	B7-H1 AntigenIBA 10/2019
1	atezolizumabIBA 10/2019
1	AntigensIBA 10/2019
1	Trichloroethylene (Trichloroethene)IBA 01/2019

Therapy/Procedure

35	Prostatectomy (Retropubic Prostatectomy) 01/2024 - 09/2010
31	Nephrectomy 01/2024 - 09/2009
24	Therapeutics 03/2024 - 04/2006
15	Nephroureterectomy 12/2024 - 01/2014
14	Castration 12/2023 - 10/2011
9	Drug Therapy (Chemotherapy) 01/2023 - 05/2012
8	Radiotherapy 03/2024 - 02/2014
5	Warm Ischemia 01/2020 - 03/2012
4	Cystectomy 11/2023 - 12/2010
4	Adjuvant Chemotherapy 01/2021 - 05/2012
3	Salvage Therapy 12/2024 - 02/2014
3	Radiofrequency Ablation 09/2022 - 07/2011
3	Operative Time 12/2014 - 09/2011
2	Urinary Diversion (Ileal Conduit) 11/2023 - 07/2013
2	Metastasectomy 12/2019 - 01/2018
2	Aftercare (After-Treatment) 12/2019 - 09/2012
2	Catheters 02/2013 - 12/2012
2	Solid-State Lasers 10/2005 - 06/2005
1	Adrenalectomy 03/2024
1	Intravesical Administration 01/2024
1	Lasers (Laser) 01/2023
1	Vasectomy (Vas Occlusion) 09/2022